NORTHERN TRUST CORP - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 76 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$1,519,457
+6.3%
518,586
+3.7%
0.00%
Q2 2023$1,430,023
-4.7%
500,008
+2.9%
0.00%
Q1 2023$1,501,236
+39.5%
485,837
-4.7%
0.00%
Q4 2022$1,075,894
+39.9%
509,902
+116.4%
0.00%
Q3 2022$769,000
-1.0%
235,642
-2.8%
0.00%
Q2 2022$777,000
-9.9%
242,389
+98.5%
0.00%
Q1 2022$862,000
-4.3%
122,089
-1.8%
0.00%
Q4 2021$901,000124,3760.00%
Other shareholders
HUMACYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Imprint Wealth LLC 257,119$938,4120.62%
Endowment Wealth Management, Inc. 96,618$298,5500.30%
Prescott General Partners LLC 568,246$1,755,8800.14%
HAMILTON LANE ADVISORS LLC 52,693$1630.06%
United Asset Strategies, Inc. 58,960$182,1860.02%
Kovack Advisors, Inc. 35,000$108,1500.02%
Shay Capital LLC 19,987$61,7600.01%
Y-Intercept (Hong Kong) Ltd 14,565$45,0060.01%
Mendota Financial Group, LLC 500$3,5300.00%
PHILADELPHIA TRUST CO 10,000$310.00%
View complete list of HUMACYTE INC shareholders